An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo

Cell Reports
Brandon J AubreyMarco J Herold

Abstract

The CRISPR/Cas9 technology enables the introduction of genomic alterations into almost any organism; however, systems for efficient and inducible gene modification have been lacking, especially for deletion of essential genes. Here, we describe a drug-inducible small guide RNA (sgRNA) vector system allowing for ubiquitous and efficient gene deletion in murine and human cells. This system mediates the efficient, temporally controlled deletion of MCL-1, both in vitro and in vivo, in human Burkitt lymphoma cell lines that require this anti-apoptotic BCL-2 protein for sustained survival and growth. Unexpectedly, repeated induction of the same sgRNA generated similar inactivating mutations in the human Mcl-1 gene due to low mutation variability exerted by the accompanying non-homologous end-joining (NHEJ) process. Finally, we were able to generate hematopoietic cell compartment-restricted Trp53-knockout mice, leading to the identification of cancer-promoting mutants of this critical tumor suppressor.

References

Jan 18, 2005·Nature Reviews. Molecular Cell Biology·Erik J Sontheimer
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Nov 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marco J HeroldHolger M Reichardt
Jan 17, 2009·Cell Death and Differentiation·E M MichalakC L Scott
Jun 21, 2012·Genes & Development·William A Freed-Pastor, Carol Prives
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Aug 24, 2013·Science·Elizabeth Pennisi
Dec 18, 2013·Cell Reports·Christof FellmannJohannes Zuber
Dec 18, 2013·Science·Tim WangEric S Lander

❮ Previous
Next ❯

Citations

Oct 5, 2015·Advances in Biological Regulation·Andrea PellagattiJacqueline Boultwood
Jul 16, 2015·European Journal of Immunology·Paul J BakerSeth L Masters
Mar 24, 2016·Cancer Letters·Volkan I Sayin, Thales Papagiannakopoulos
Jun 11, 2015·Genome Medicine·Haiwei MouWen Xue
Dec 18, 2015·Journal of Medical Genetics·Hui-Ying XueXiao-Jie Lu
Aug 9, 2016·Briefings in Functional Genomics·Tomoko Kato, Shuji Takada
Aug 29, 2016·Advanced Drug Delivery Reviews·I Cody MacDonald, Tara L Deans
May 25, 2016·Annual Review of Genomics and Human Genetics·Xin XiongLei S Qi
Sep 7, 2016·Nature Structural & Molecular Biology·Thomas ClairfeuilleBrett M Collins
Aug 27, 2016·Expert Opinion on Drug Discovery·Sanil BhatiaJulia Hauer
Sep 14, 2016·The Journal of Experimental Medicine·Alex R D DelbridgeAndreas Strasser
Sep 14, 2016·British Journal of Haematology·Han Zhang, Nami McCarty
Oct 25, 2016·Biochimica Et Biophysica Acta·Lang Yi, Jinming Li
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Van Trung ChuKlaus Rajewsky
Oct 14, 2016·Nucleic Acids Research·Chance M NowakLeonidas Bleris
Oct 28, 2016·Nature·András KotschyOlivier Geneste
Mar 11, 2017·Nature Communications·Markus C KerrRohan D Teasdale
Apr 15, 2017·Cell Death and Differentiation·Jason A GlabHamsa Puthalakath
May 21, 2017·Science China. Life Sciences·Zhi-Yao HeYu-Quan Wei
Feb 8, 2018·European Journal of Immunology·Katharina HochheiserMarco J Herold
Dec 13, 2017·Cell Death and Differentiation·Lisa M LindqvistDavid L Vaux
May 9, 2018·Immunology and Cell Biology·Damien ZankerWeisan Chen
Jan 13, 2018·Genome Research·Wonjoo KimHyongbum Henry Kim
Jun 17, 2018·Genes & Development·Sang-Kyu KimRicky W Johnstone
Sep 1, 2018·Expert Opinion on Drug Delivery·D C LutherV M Rotello
Oct 28, 2018·Genes & Development·Brandon J AubreyGemma L Kelly
Nov 2, 2018·Proceedings of the National Academy of Sciences of the United States of America·Ivano AmelioGerry Melino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Related Papers

Methods : a Companion to Methods in Enzymology
Andrew R Bassett, Ji-Long Liu
Diagnostic Cytopathology
Edward B StelowRobin D LeGallo
Seminars in Cancer Biology
Eva Klein, George Klein
© 2022 Meta ULC. All rights reserved